Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Authors
Keywords
Cardiovascular mortality, Copeptin, Coronary heart disease, Diabetes, Epidemiology, Stroke
Journal
DIABETOLOGIA
Volume 59, Issue 9, Pages 1904-1912
Publisher
Springer Nature
Online
2016-06-16
DOI
10.1007/s00125-016-4011-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Copeptin is an independent predictor of diabetic heart disease and death
- (2015) Sofia Enhörning et al. AMERICAN HEART JOURNAL
- Cohort Profile Update: The British Regional Heart Study 1978–2014: 35 years follow-up of cardiovascular disease and ageing
- (2015) Lucy T Lennon et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men
- (2015) S. Goya Wannamethee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic role of copeptin after stroke: A systematic review and meta-analysis of observational studies
- (2015) Kyu-Sun Choi et al. Scientific Reports
- Water Deprivation Induces Neurovascular and Cognitive Dysfunction through Vasopressin-Induced Oxidative Stress
- (2014) Giuseppe Faraco et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- All-Cause and Cardiovascular Mortality in Middle-Aged People With Type 2 Diabetes Compared With People Without Diabetes in a Large U.K. Primary Care Database
- (2013) K. S. Taylor et al. DIABETES CARE
- Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)
- (2013) I. J. Riphagen et al. DIABETES CARE
- Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33)
- (2013) W. E. Boertien et al. DIABETOLOGIA
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2013) EUROPEAN HEART JOURNAL
- N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study
- (2013) S. Goya Wannamethee et al. EUROPEAN JOURNAL OF HEART FAILURE
- Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction
- (2012) Mihael Potocki et al. HEART
- Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease
- (2012) Stephan von Haehling et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort
- (2012) S Enhörning et al. INTERNATIONAL JOURNAL OF OBESITY
- Diabetes, hyperglycaemia, and acute ischaemic stroke
- (2012) Merel JA Luitse et al. LANCET NEUROLOGY
- Copeptin Levels Associate with Cardiovascular Events in Patients with ESRD and Type 2 Diabetes Mellitus
- (2011) W. Fenske et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Copeptin, IGFBP-1, and Cardiovascular Prognosis in Patients With Type 2 Diabetes and Acute Myocardial Infarction: A report from the DIGAMI 2 trial
- (2010) L. G. Mellbin et al. DIABETES CARE
- Impact of Microalbuminuria on Incident Stroke
- (2010) Meng Lee et al. STROKE
- Endothelial Markers May Link Kidney Function to Cardiovascular Events in Type 2 Diabetes
- (2009) C. Maier et al. DIABETES CARE
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes
- (2009) DIABETES CARE
- Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives
- (2009) Dirk Sander et al. JOURNAL OF NEUROLOGY
- Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort
- (2009) Esther Meijer et al. KIDNEY INTERNATIONAL
- Additive Interaction of Hyperglycemia and Albuminuria on Risk of Ischemic Stroke in Type 2 Diabetes: Hong Kong Diabetes Registry
- (2008) X. Yang et al. DIABETES CARE
- Altered lipid metabolism in vasopressin V1B receptor-deficient mice
- (2008) Masami Hiroyama et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Comparison of Copeptin, B-Type Natriuretic Peptide, and Amino-Terminal Pro-B-Type Natriuretic Peptide in Patients With Chronic Heart Failure
- (2008) Stephanie Neuhold et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started